Reviva Pharmaceuticals Holdings, Inc.
(NASDAQ : RVPH)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 0.04%172.250.7%$1088.53m
PFEPfizer Inc. -0.02%42.780.9%$1062.98m
AZNAstraZeneca Plc -0.69%57.241.0%$983.21m
MRKMerck & Co., Inc. -0.13%76.830.7%$651.89m
ABBVAbbVie, Inc. -2.22%116.231.9%$651.72m
BMYBristol-Myers Squibb Co. -0.34%67.921.0%$580.36m
LLYEli Lilly & Co. -0.80%243.361.1%$577.91m
NRXPNRX Pharmaceuticals, Inc. 0.20%15.180.0%$167.78m
NVSNovartis AG 0.25%92.420.2%$154.78m
GSKGlaxoSmithKline Plc 0.13%40.150.2%$154.55m
RGENRepligen Corp. 1.95%245.706.8%$95.53m
VTRSViatris, Inc. -1.54%14.070.0%$86.29m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. -0.06%126.060.0%$85.37m
NVONovo Nordisk A/S 1.32%92.580.1%$81.36m
RPRXRoyalty Pharma Plc -0.13%38.200.2%$73.90m

Company Profile

Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the central nervous system, respiratory, and metabolic diseases. It uses chemical genomics driven technology platform and proprietary chemistry to develop new medicines. It focuses on RP5063 (Brilaroxazine) and RP1208 pipelines. The company was founded on December 11, 2020 and is headquartered in Cupertino, CA.